Advertisement

THE RELATIONSHIP OF RECEIVING LUNG CANCER SCREENING WITH RECEIVING TOBACCO CESSATION MEDICATION AND PNEUMONIA VACCINE

      TOPIC: Tobacco Cessation and Prevention
      TYPE: Original Investigations
      PURPOSE: The stage at diagnosis is the single most important predictor of lung cancer outcome, making early detection of lung cancer of utmost importance. National lung screening trial found significant benefit from screening with low dose Computed tomography (LDCT). Despite this, less than 4 % of the high-risk population get annual LDCT. Patients' attitudes towards tobacco usage and preventive care can be a factor in getting LDCT. Here in our study, we analyze the relationship between the willingness to undergo LDCT and a person's readiness to try tobacco cessation medication or get the pneumococcal vaccine. And if there is any relation between tobacco cessation counseling and readiness for LDCT, pneumococcal vaccine, or tobacco cessation medication.
      METHODS: The study's approval was obtained from the East Tennessee state university (ETSU) institutional review board. Clinic records of high-risk patients seen in the ETSU clinics between 1/1/2016 and 11/30/2020 were analyzed retrospectively. Patients who were active smokers and between the ages of 55 and 80 with 30 or more pack-years were included in the study. Patients with known lung cancer were excluded
      RESULTS: Records of 11,136 patients in the age group were analyzed. A total of 2,834 patients were current smokers. The median age of the study cohort was 63. A total of 570 patients (screening group) had at least one LDCT screening done during the study period (Vs. 2264 without any LDCT [no screening group]). 22.8% (N=130) patients in the screening group tried one of the tobacco cessation medications at least once during the study period (Vs. 9.8% [N=223] in the no screening group), Odds ratio (OR) 2.70, 95% CI [2.12,3.4]. 71.5% (N=408) patients in the screening group received at least one dose of pneumonia vaccine (Vs. 35.5% [N=804] in the no screening group), OR 4.57, 95% CI [3.73,5.59]. 80.7% (N=460) in the screening group had received tobacco cessation counseling (Vs. 53.5%(N=1213) in the no screening group). Out of people who received at least one tobacco cessation counseling, 27.5% (N=460) got low dose CT screening (Vs. 9.5% among those who never received counseling), OR 3.62, 95% CI [2.89,4.53]. 15.6% (N=262) of those who got tobacco cessation counseling received tobacco cessation medications (Vs. 7.8%(N=91) among those who never had counseling).
      CONCLUSIONS: Our study clearly shows a relationship between getting LDCT and getting a pneumonia vaccine or tobacco cessation medication. We were also able to conclude that tobacco cessation counseling increased the odds of getting LDCT, tobacco cessation medication, and pneumonia vaccine.
      CLINICAL IMPLICATIONS: Clinicians should ensure smoking cessation counseling is done at every visit, and the patient is well informed about lung cancer screening.
      DISCLOSURES: No relevant relationships by Girendra Hoskere, source=Web Response
      No relevant relationships by Akesh Thomas, source=Web Response